L. Sbârcea et al.
1
6. Flekhter OB, Ashavina OY, Boreko EI, Karachurina LT, Pavlova
NI, Kabalnova NN, Savinova OV, Galin FZ, Nikolaeva SN,
Zarudii FS, Baltina L, Tolstikov G. Synthesis of 3-O-acetylbe-
tulinic and betulonic aldehydes according to Svern and the
pharmacological activity of related oximes. Pharm Chem J.
31. Brusnikina M, Silyukov O, Chislov M, Volkova T, Proshin A,
Mazur A, Tolstoy P, Terekhova I. Effect of cyclodextrin com-
plexation on solubility of novel anti-Alzheimer 1,2,4-thiadiazole
derivative. J Therm Anal Calorim. 2017;130:443–50.
32. Sb aˆ rcea L, Udrescu L, Dr a˘ gan L, Trandafirescu C, Sasca V,
Barvinschi P, Boji ¸t a˘ M. Characterization of fosinopril natrium-
hydroxypropil-β-cyclodextrin inclusion complex. Rev Chim
Buchar. 2011;62(3):349–51.
33. Ikeda H, Fukushige Y, Matsubara T, Inenaga M, Kawahara M,
Yukawa M, Fujisawa M, Yukawa E, Aki H. Improving water
solubility of nateglinide by complexation of β-cyclodextrin.
J Therm Anal Calorim. 2016;123:1847–50.
34. Sb aˆ rcea L, Lede ¸t i I, Dr a˘ gan L, Kurunczi L, Fulia s¸ A, Udrescu L.
Fosinopril sodium–Hydroxypropyl-β-cyclodextrin inclusion
complex. Thermal decomposition kinetics and compatibility
studies. J Therm Anal Calorim. 2015;120:981–90.
2
002;36:303–6.
1
1
7. Govdi AI, Sorokina IV, Tolstikova TG, Vasilevsky SF, Tolstikov
GA. Synthesis and biological activity of novel acetylene betu-
lonic acid derivatives. Chem Sustain Dev. 2010;18:397–402.
8. Vasilevsky SF, Govdi AI, Shults EE, Shakirov MM, Sorokina IV,
Tolstikova TG, Baev DS, Tolstikov GA, Alabugin IV. Efficient
synthesis of the first betulonic acid-acetylene hybrids and their
hepatoprotective and anti-inflammatory activity. Bioorg Med
Chem. 2009;17:5164–9.
1
2
9. Saxena BB, Zhu L, Hao M, Kisilis E, Katdare M, Oktem O,
Bomshteyn A, Rathnam P. Boc-lysinated-betulonic acid: a
potent, anti-prostate cancer agent. Bioorg Med Chem.
35. Stella VJ, He Q. Cyclodextrins. Toxicol Pathol. 2008;36:30–42.
36. Laza-Knoerr AL, Gref R, Couvreur P. Cyclodextrin for drug
delivery. J Drug Target. 2010;18:645–56.
2
006;14:6349–58.
0. Semenov DE, Zhukova NA, Ivanova EP, Sorokina IV, Baiev DS,
Nepomnyashchikh GI, Tolstikova TG, Biryukova MS. Hepato-
protective properties of betulonic acid amide and heptral in toxic
liver injury induced by carbon tetrachloride in combination with
ethanol. Bull Exp Biol Med. 2015;158(3):336–41.
1. Dinh Ngoc T, Moons N, Kim Y, De Borggraeve W, Mashentseva
A, Andrei G, Snoeck R, Balzarini J, Dehaen W. Synthesis of
triterpenoid triazine derivatives from allobetulone and betulonic
acid with biological activities. Bioorg Med Chem. 2014;22
37. Brusnikina M, Silyukov O, Chislov M, Volkova T, Proshin A,
Terekhova I. New water-soluble dosage forms of 1,2,4-thiadia-
zole derivative on the basis of inclusion complexes with
cyclodextrins. J Therm Anal Calorim. 2017;127:1815–24.
38. Fontanay S, Kedzierewicz F, Duval RE, Clarot I. Physicochem-
ical and thermodynamic characterization of hydroxyl pentacyclic
triterpenoid acid/γ-cyclodextrin inclusion complexes. J Incl
Phenom Macrocycl Chem. 2012;73(1):341–7.
39. S¸ oica CM, Danciu C, S a˘ voiu-Balint G, Borcan F, Ambrus R,
Zupko I, Bojin F, Coricovac D, Ciurlea S, Avram S¸ , Dehelean
CA, Olariu T, Matusz P. Betulinic acid in complex with a
gamma-cyclodextrin derivative decreases proliferation and
in vivo tumor development of non-metastatic and metastatic
B164A5 Cells. Int J Mol Sci. 2014;15(5):8235–55.
2
2
(13):3292–300.
2. Haque Shafiul, Nawrot Dorota A, Alakurtti Sami, Ghemtio Leo,
Yli-Kauhaluoma Jari, Tammela P a¨ ivi. Screening and characteri-
2
3. Anikina LV, Tolmacheva IA, Vikharev YuB, Grishko VV. The
immunotropic activity of lupane and oleanane 2,3-seco-triter-
penoids. Russ J Bioorg Chem. 2010;36:240–4.
40. Zong W, Bi SM. The preparation and characterization of inclu-
sion complex of ursolic acid with γ-cyclodextrin. Adv Mater Res.
2012;403–408:712–6.
2
4. Sorokina IV, Tolstikova TG, Zhukova NA, Petrenko NI, Schults
EE, Uzenkova NV, Grek OR, Pozdnyakova SV, Tolstikov GA.
Betulonic acid and derivatives, a new group of agents reducing
side effects of cytostatics. Dokl Biol Sci. 2004;339:434–7.
5. Loftsson T, Jarho P, Masson M, Jarvinen T. Cyclodextrins in
drug delivery. Expert Opin Drug Deliv. 2005;2:335–51.
6. D’Aria F, Serri C, Niccoli M, Mayol L, Quagliariello V, Iaffaioli
RV, Biondi M, Giancola C. Host–guest inclusion complex of
quercetin and hydroxypropyl-β-cyclodextrin. J Therm Anal
Calorim. 2017;130:451–6.
41. Ren Y, Liu Y, Yang Z, Niu R, Gao K, Yang B, Liao X, Zhang J.
Solid inclusion complexes of oleanolic acid with amino-appended
β-cyclodextrins (ACDs): preparation, characterization, water
solubility and anticancer activity. Mater Sci Eng C. 2016;69:68–
76.
42. S¸ oica CM, Peev CI, Ciurlea S, Ambrus R, Dehelean CA. Physico-
chemical and toxicological evaluations of betulin and betulinic
acid interactions with hydrophilic cyclodextrins. Farmacia.
2010;58(5):611–9.
43. Dehelean CA, S¸ oica CM, Peev CI, Gruia AT, S¸ eclaman E.
Physico-chemical and molecular analysis of antitumoral penta-
cyclic triterpenes in complexation with gamma-cyclodextrin. Rev
Chim Buchar. 2008;59:887–90.
44. Claude B, Morin Ph, Lafosse M, Andre P. Evaluation of apparent
formation constants of pentacyclic triterpene acids complexes
with derivatized β- and γ-cyclodextrins by reversed phase liquid
chromatography. J Chromatogr A. 2004;1049:37–42.
45. Ledeti I, Bosca CS, Cosma C, Badea V, Todea A, Bercean VN.
Study on obtaining 3-oxolup-20(29)-en-28-oic acid (betulonic
acid) from (3β)-lup-20(29)-en-3,28-diol (betulin). Rev Chim
Buchar. 2014;65(11):1289–93.
46. Chislov M, Silyukov O, Kumeev R, Proshin A, Perlovich G,
Terekhova I. Complex formation of cyclodextrins with some
pharmacologically active 1,2,4-thiadiazole derivatives. J Therm
Anal Calorim. 2017;127:1797–805.
47. Benesi HA, Hildebrand JH. A spectrophotometric investigation
of the interaction of iodine with aromatic hydrocarbons. J Am
Chem Soc. 1949;71(8):2703–7.
48. Sal u´ stio J, Feio G, Figueirinhas JL, Pinto JF, Cabral Marques
HM. The influence of the preparation methods on the inclusion of
2
2
2
7. Garcia A, Leonardi D, Salazar MO, Lamas MC. Modified β-
cyclodextrin inclusion complex to improve the physicochemical
2
8. Sb aˆ rcea L, Udrescu L, Lede ¸t i I, Szabadai Z, Fulia s¸ A, Sb aˆ rcea C.
β-cyclodextrin inclusion complexes of lisinopril and zofenopril.
Physicochemical characterization and compatibility study of
lisnopril-β-cyclodextrin with lactose. J Therm Anal Calorim.
2
016;123:2377–90.
2
3
9. Sb aˆ rcea L, Udrescu L, Dr a˘ gan L, Trandafirescu C, Szabadai Z,
Boji ¸t a˘ M. Fosinopril–cyclodextrin inclusion complexes: phase
solubility
2
and
physicochemical
analysis.
Pharmazie.
011;66:584–9.
0. Cȋrcioban D, Lede ¸t i A, Vlase G, Coricovac D, Moaca A, Farca s¸
C, Vlase T, Lede ¸t i I, Dehelean C. Guest–host interactions and
complex formation for artemisinin with cyclodextrins: instru-
mental analysis and evaluation of biological activity. J Therm
Anal Calorim. 2018;134:1375–84.
1
23